PROBLEM TO BE SOLVED: To provide a pharmaceutical composition comprising of preparations of human embryonic stem (hES) cells and their derivatives and methods for their transplantation into the human body.SOLUTION: The invention relates to a pharmaceutical composition, in pre-filled syringe, wherein hES cells and/or their derivatives which are free of animal products, feeder cells, growth factors, leukaemia inhibitory factor, supplementary mineral combinations, amino acid supplements, vitamin supplements, fibroblast growth factor, membrane associated steel factor, soluble steel factor and conditioned media are suspended into a pharmaceutically acceptable biocompatibility solution.【課題】ヒト胚性幹(hES)細胞およびそれらの誘導体の調製物を含む薬学的組成物、ならびにヒト身体へのそれらの移植のための方法の提供。【解決手段】動物性産物、フィーダー細胞、成長因子、白血病抑制因子、補充性ミネラル組み合わせ、アミノ酸補充物、ビタミン補充物、線維芽細胞成長因子、膜結合性スチール因子(steel factor)、可溶性スチール因子、および条件培地を伴わないhES細胞および/またはそれらの誘導体が薬学的に許容される生体適合性溶液に懸濁されている、薬学的組成物であって、あらかじめ注射器に充填された薬学的組成物。【選択図】なし
